Kevin R Loughlin1. Show Affiliations » 1. Brigham and Women's Hospital, Boston, MA, USA.
Abstract
Entities: Disease
Mesh： See more » Antineoplastic Agents/therapeutic useBasic Helix-Loop-Helix Transcription Factors/geneticsBasic Helix-Loop-Helix Transcription Factors/metabolismBasic Helix-Loop-Helix Transcription Factors/physiologyCarcinoma, Renal Cell/drug therapyCarcinoma, Renal Cell/geneticsCarcinoma, Renal Cell/physiopathologyGene Expression Regulation, Neoplastic/drug effectsHumansHypoxia-Inducible Factor 1/geneticsHypoxia-Inducible Factor 1/metabolismHypoxia-Inducible Factor 1/physiologyModels, BiologicalProtein Kinase Inhibitors/therapeutic use
Substances： See more » Antineoplastic AgentsBasic Helix-Loop-Helix Transcription FactorsHypoxia-Inducible Factor 1Protein Kinase Inhibitorsendothelial PAS domain-containing protein 1
Year: 2009 PMID： 19414110 DOI： 10.1016/j.urolonc.2008.08.006
Source DB: PubMed Journal: Urol Oncol ISSN： 1078-1439 Impact factor: 3.498